EC launches innovation partnerships to foster sustainable research
02.03.2012 - With three new Innovation Partnerships, the European Commission (EC) intends to eliminate weaknesses, bottlenecks and obstacles in the European research and innovation system.
The key challenges to be met are the supply of raw materials, sustainable agriculture, and active and healthy ageing. It’s the Commission’s view that all three require a more concerted innovation effort across the public and private sector, in order to improve quality of life and position Europe as a global leader. The agricultural productivity and sustainability partnership aims at the reversal of the recent trend of diminishing productivity gains and targets to improve soil quality to a satisfactory level by 2020. In order to increase innovation supporting exploration, extraction and processing of raw materials, the Commission launched the raw materials partnership. The project is set to improve recycling of electronic equipment and other waste and calls for the development of substitutes for critical raw materials. Finally, the European Innovation Partnership on active and healthy ageing seeks solutions for the demographic change in Europe. The number of European citizens aged 65 and over will double over the next 50 years. This poses the European care and social systems to a challenge and calls for redesigning these systems in the interest of patients, healthcare systems and the innovative industry.
16.12.2014 Two consortia combined of 144 European companies, research institutes and universities have been selected for funding by the EIT in the areas of health and raw materials. Both clusters are set to acquire €1.1bn over the next seven years.
10.12.2014 When it comes to the biggest investors in Research and Development (R&D) Swiss pharma top dogs Novartis and Roche have defended their positioning among the top ten companies worldwide – according to a recently published EU study.
05.12.2014 Austrian contract research company VTU has entered into a development and commercialisation agreement with US company RCT. The partners want to combine both companies' Pichia pastoris protein production technologies under VTU's roof.
03.12.2014 Danish biotech pharma Ascendis has successfully completed a €48m Series D financing round. The funding is expected to support its late-stage clinical trials to push its lead drug into Phase III trials.